We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Regeneron Pharmaceuticals, Inc.

Following the sale of the direct-to-consumer genetic testing company 23andMe, the Utah Attorney General’s Office is issuing a ...

Anne Wojcicki's nonprofit TTAM acquires 23andMe for $305 million, ending the gene-testing pioneer's bankruptcy saga. The deal still faces state regulators' objections over genetic data control.

Anne Wojcicki, co-founder of 23andMe, a DNA testing company, has won back control of the firm through a bankruptcy court sale.

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, promising to honor existing privacy protections and continue consumer services ...

Officials for retailer Claire's filed for bankruptcy protection on Wednesday as its operating costs rise while demand for its ...

In May, Regeneron Pharmaceuticals announced it would purchase most of 23andMe's assets for $256 million after it came out on top during the bankruptcy auction.

July 14 at 11:59 p.m. CT is your last chance to file a claim with 23andMe for a 2023 data breach that may have compromised your genetic data.

Today is the deadline for 23andMe customers to submit a claim for compensation, if eligible.

Shares of Regeneron Pharmaceuticals Inc. REGN slipped 1.36% to $542.52 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0. ...